BRAF V600E mutation is a predictive indicator of upfront chemotherapy for stage IV colorectal cancer

Tatsuya Morikawa, Ryo Inada, Takeshi Nagasaka, Yoshiko Mori, Hiroyuki Kishimoto, Takashi Kawai, Yuzo Umeda, Hideyuki Mishima, Ajay Goel, Toshiyoshi Fujiwara

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Fingerprint Dive into the research topics of 'BRAF V600E mutation is a predictive indicator of upfront chemotherapy for stage IV colorectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences